A carregar...
Sunitinib causes macrocytosis in patients with advanced renal cell carcinoma
BACKGROUND: Sunitinib is approved for treatment of advanced renal cell carcinoma (rcc). Based on a clinical observation that patients receiving sunitinib developed macrocytosis, we undertook a study to further define this observation. METHODS: In a retrospective review of rcc patients treated at a s...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Multimed Inc.
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2854633/ https://ncbi.nlm.nih.gov/pubmed/20404975 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|